1. Home
  2. PZZA vs EVO Comparison

PZZA vs EVO Comparison

Compare PZZA & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Papa John's International Inc.

PZZA

Papa John's International Inc.

HOLD

Current Price

$36.42

Market Cap

1.2B

ML Signal

HOLD

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$2.76

Market Cap

994.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PZZA
EVO
Founded
1984
1993
Country
United States
Germany
Employees
N/A
4553
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
994.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
PZZA
EVO
Price
$36.42
$2.76
Analyst Decision
Buy
Strong Buy
Analyst Count
8
1
Target Price
$45.00
$7.00
AVG Volume (30 Days)
1.0M
29.4K
Earning Date
05-07-2026
04-08-2026
Dividend Yield
5.25%
N/A
EPS Growth
N/A
N/A
EPS
0.21
N/A
Revenue
$2,068,421,000.00
N/A
Revenue This Year
N/A
$1.37
Revenue Next Year
N/A
$10.05
P/E Ratio
$172.24
N/A
Revenue Growth
14.07
N/A
52 Week Low
$30.16
$2.31
52 Week High
$55.74
$4.42

Technical Indicators

Market Signals
Indicator
PZZA
EVO
Relative Strength Index (RSI) 60.07 48.27
Support Level $35.50 $2.60
Resistance Level $38.22 $3.82
Average True Range (ATR) 1.53 0.07
MACD 0.43 0.00
Stochastic Oscillator 75.66 66.07

Price Performance

Historical Comparison
PZZA
EVO

About PZZA Papa John's International Inc.

Papa John's International Inc operates and franchises pizza delivery and carryout restaurants and, in certain international markets, dine-in and delivery restaurants. It has four defined reportable segments: Domestic Company-owned restaurants, North America franchising, North America commissaries, and International. The company derives maximum revenue from North America commissaries segment. The North America commissaries segment consists of the operations of its regional dough production and product distribution centers in the United States and Canada and derives its revenues principally from the sale and distribution of food and paper products to Domestic Company-owned and franchised restaurants in the United States and Canada.

About EVO Evotec SE

Evotec SE is a life science company focused on developing pharmaceutical products through standalone services, integrated R&D programs, and strategic partnerships with pharmaceutical and biotechnology companies, academic institutions, and other partners. It operates across drug discovery, preclinical development, and manufacturing, with expertise in areas including oncology, central nervous system, cardiovascular-renal, immune and inflammatory, infectious, and other diseases. The Company generates revenue through fee-for-service and FTE-based services, milestones, and royalties, and equity ownership in biotechnology and academic projects. It operates through the Shared R&D and Discovery & Preclinical Development (D&PD) segments, with the majority of revenue generated from the USA.

Share on Social Networks: